Metraipolis › archive › dc_063bbd60e16d

Feasibility of [99mTc]Tc-Mannosylated Human Serum Albumin for Lymphoscintigraphy: A Phase 1/2 Clinical Trial — Europe PMC PMID:42273654

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42273654
DOI
10.1007/s13139-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-09T19:37:46.246Z
SHA-256 of the archived text
fcfa5c867e5f9f5e5fadb706f058c6bda214eb2ebc5eee00d3225e9fadf1de78
Stable URL of this page
https://metraipolis.com/documento/dc_063bbd60e16d

How to cite

Feasibility of [99mTc]Tc-Mannosylated Human Serum Albumin for Lymphoscintigraphy: A Phase 1/2 Clinical Trial — Europe PMC PMID:42273654 — Europe PMC (en), https://europepmc.org/article/MED/42273654 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_063bbd60e16d (Metraipolis archive dc_063bbd60e16d, sha256 fcfa5c867e5f9f5e5fadb706f058c6bda214eb2ebc5eee00d3225e9fadf1de78)
BibTeX
@misc{dc063bbd60e16d,
  title = {Feasibility of [99mTc]Tc-Mannosylated Human Serum Albumin for Lymphoscintigraphy: A Phase 1/2 Clinical Trial — Europe PMC PMID:42273654},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42273654},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_063bbd60e16d; sha256 fcfa5c867e5f9f5e5fadb706f058c6bda214eb2ebc5eee00d3225e9fadf1de78},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42273654. Agents can read the archived copy with the MCP tool read_document.